Pharm2 market - Business Intelligence for Biotechs
•
0 likes•33 views
Pharm2Market is a new business intelligence service designed to help biotech sales and marketing professionals find new customers.
Report
Share
Report
Share
Download to read offline
Recommended
Pharmaceutical companies and SEO search results compliance
This paper looks at two search components (from an optimisation perspective and a pharama compliance perspective) that are publicly visible in search engine results: the ‘Title Tag’ and the ‘Description Tag’.
Search results are important because they are the first piece of information a person sees before clicking and entering a web property and should comply with FDA and PMCPA regulations.
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...Bare Sky Marketing Healthcare Content Writing Services
Walgreens Boots Alliance ( NASDAQ: WBA ) ranks at number 17 on the Fortune 500 list of largest firms. Reportedly they are exploring options to take the company private which may also be a strong signal to other industry leaders that it is open to takeover offers. Regardless of what their ultimate goals are, they remain a global force in retail, pharmacy, wholesaler and other sectors. The company’s CEO, Stefano Pessina, has communicated Walgreens is actively pursuing more partnerships as a business strategy that enable it to generate revenue by asserting its corporate, financial, clinical and operations resources to build market access and revenue while disrupting competitors — without having to deploy funding for complete acquisitions that contribute to further to debt loads.
Primary elements of Walgreens Boots Alliance financial profile:
- Market capitalization of $50 billion
- Annual sales: $136.86 billion ( 2019 figures which represented a 5.8% increase over 2018 )
- Earnings: $3.982 billion
- Debt: $15 billion
- Ownership stake of 16% held by CEO Stefano Pessina
Strategic global attributes of WBA
- Business operations in more than 25 nations
- Over 415,000 employees
- More than 18,500 stores located in 11 countries
- Over 390 distribution centers servicing pharmacies ( including pharmacies not owned by WBA ), physician offices and healthcare provider organizations
- Ownership stake of 26% in AmerisourceBergen ( NYSE: ABC ), a global leader in healthcare wholesaler operations ranked at number 12 on the Fortune 500 list; annual sales of $153 billion
Key Points:
- Leading companies seeking strategic alliances with Walgreens
Kroger, McKesson, Microsoft and Prime Therapeutics collaborating with Walgreens
- Brand marketing, pharmacy, market access and technology partnerships driving revenue for Walgreens and partners
- Global and domestic market access, commercial synergies and profit in strategic partnerships
Read the article for complete details on each of the strategic partnerships Walgreens has in place with Kroger, McKesson, Microsoft, Prime Therapeutics
Contact John Baresky for additional details
Application of BI in pharmaceutical industry
A whitepaper from MicroStrategy Inc. on the application of BI in the pharma industry. Source: open internet
San Diego By The Numbers
We took a look at the stats on drug discovery companies in the San Diego area to see what we could learn about the community and how it works. Here are the results.
Tracxn Startup Research — Life Sciences Landscape, October 2016
There were 20+ acquisitions in this space in 2016; IBM’s $2.6B acquisition of Truven Analytics, and Affymetrix’s acquisition by Thermo Fisher Scientific for $1.6B were the largest M&A events for the sector this year.
International market entry planning (in the generic pharma industry)
Ideas and opportunities for entering new markets in the generic pharmaceutical industry
Recommended
Pharmaceutical companies and SEO search results compliance
This paper looks at two search components (from an optimisation perspective and a pharama compliance perspective) that are publicly visible in search engine results: the ‘Title Tag’ and the ‘Description Tag’.
Search results are important because they are the first piece of information a person sees before clicking and entering a web property and should comply with FDA and PMCPA regulations.
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...Bare Sky Marketing Healthcare Content Writing Services
Walgreens Boots Alliance ( NASDAQ: WBA ) ranks at number 17 on the Fortune 500 list of largest firms. Reportedly they are exploring options to take the company private which may also be a strong signal to other industry leaders that it is open to takeover offers. Regardless of what their ultimate goals are, they remain a global force in retail, pharmacy, wholesaler and other sectors. The company’s CEO, Stefano Pessina, has communicated Walgreens is actively pursuing more partnerships as a business strategy that enable it to generate revenue by asserting its corporate, financial, clinical and operations resources to build market access and revenue while disrupting competitors — without having to deploy funding for complete acquisitions that contribute to further to debt loads.
Primary elements of Walgreens Boots Alliance financial profile:
- Market capitalization of $50 billion
- Annual sales: $136.86 billion ( 2019 figures which represented a 5.8% increase over 2018 )
- Earnings: $3.982 billion
- Debt: $15 billion
- Ownership stake of 16% held by CEO Stefano Pessina
Strategic global attributes of WBA
- Business operations in more than 25 nations
- Over 415,000 employees
- More than 18,500 stores located in 11 countries
- Over 390 distribution centers servicing pharmacies ( including pharmacies not owned by WBA ), physician offices and healthcare provider organizations
- Ownership stake of 26% in AmerisourceBergen ( NYSE: ABC ), a global leader in healthcare wholesaler operations ranked at number 12 on the Fortune 500 list; annual sales of $153 billion
Key Points:
- Leading companies seeking strategic alliances with Walgreens
Kroger, McKesson, Microsoft and Prime Therapeutics collaborating with Walgreens
- Brand marketing, pharmacy, market access and technology partnerships driving revenue for Walgreens and partners
- Global and domestic market access, commercial synergies and profit in strategic partnerships
Read the article for complete details on each of the strategic partnerships Walgreens has in place with Kroger, McKesson, Microsoft, Prime Therapeutics
Contact John Baresky for additional details
Application of BI in pharmaceutical industry
A whitepaper from MicroStrategy Inc. on the application of BI in the pharma industry. Source: open internet
San Diego By The Numbers
We took a look at the stats on drug discovery companies in the San Diego area to see what we could learn about the community and how it works. Here are the results.
Tracxn Startup Research — Life Sciences Landscape, October 2016
There were 20+ acquisitions in this space in 2016; IBM’s $2.6B acquisition of Truven Analytics, and Affymetrix’s acquisition by Thermo Fisher Scientific for $1.6B were the largest M&A events for the sector this year.
International market entry planning (in the generic pharma industry)
Ideas and opportunities for entering new markets in the generic pharmaceutical industry
PCD PHARMA FRANCHISE COMPANY - AROGYA FORMULATIONS PVT LTD..pptx
Arogya Formulations is a leading PCD Pharma Franchise Company that specializes in offering a wide range of high-quality pharmaceutical products. With a commitment to health and wellness, the company provides excellent opportunities for individuals and businesses to join their PCD (Propaganda Cum Distribution) Pharma franchise network. Arogya Formulations focuses on delivering innovative and affordable healthcare solutions, ensuring the availability of top-notch pharmaceutical products across various therapeutic segments. The company's dedication to quality, integrity, and customer satisfaction makes it a trusted partner for those seeking to establish a successful presence in the pharmaceutical industry through franchise opportunities.
Visit us at: https://arogyaformulations.com/pcd-pharma-franchise-company/
How is digital innovation affecting the pharmaceutical industry- Presentation
The GrowthEnabler InFocus reports uniquely address the top priorities for technology leaders and their teams; by recommending potential solutions, in the context of business growth. Each business priority is broken down to point level/function-specific solutions that are further linked to technologies with a list of vendors. Business Solutions are sourced from GrowthEnabler Pii, our intelligence gateway to over 525K high growth tech companies. This report is designed to navigate the ever-changing technology landscape, and enable more informed, and quicker, decision making.
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Figure 2.2The Five Forces of Competition Model
The five forces of competition model depicted in Figure 2.2 expands the scope of a firm’s competitive analysis. Historically, when studying the competitive environment, firms concentrated on companies with which they directly competed. However, firms must search more broadly to recognize current and potential competitors by identifying potential customers as well as the firms serving them. For example, the communications industry is now broadly defined as encompassing media companies, telecoms, entertainment companies, and companies producing devices such as smartphones. In such an environment, firms must study many other industries to identify companies with capabilities (especially technology-based capabilities) that might be the foundation for producing a good or a service that can compete against what they are producing.
When studying the industry environment, firms must also recognize that suppliers can become a firm’s competitors (by integrating forward) as can buyers (by integrating backward). For example, several firms have integrated forward in the pharmaceutical industry by acquiring distributors or wholesalers. In addition, firms choosing to enter a new market and those producing products that are adequate substitutes for existing products can become a company’s competitors.
Next, we examine the five forces the firm needs to analyze in order to understand the profitability potential within an industry (or a segment of an industry) in which it competes or may choose to compete.
The Internal Organization: Resources, Capabilities, Core Competencies, and Competitive Advantages
· Chapter Introduction
· 3-1Analyzing the Internal Organization
· 3-1aThe Context of Internal Analysis
· 3-1bCreating Value
· 3-1cThe Challenge of Analyzing the Internal Organization
· 3-2Resources, Capabilities, and Core Competencies
· 3-2aResources
· 3-2bCapabilities
· 3-2cCore Competencies
· 3-3Building Core Competencies
· 3-3aThe Four Criteria of Sustainable Competitive Advantage
· 3-3bValue Chain Analysis
· 3-4Outsourcing
· 3-5Competencies, Strengths, Weaknesses, and Strategic Decisions
· Chapter Review
· Summary
· Key Terms
· Review Questions
· Mini-Case Is Strengthening the Superdry Brand a Foundation to Strategic Success?Chapter Introduction
iStock.com/DNY59Learning Objectives
Studying this chapter should provide you with the strategic management knowledge needed to:
· 3-1Explain why firms need to study and understand their internal organization.
· 3-2Define value and discuss its importance.
· 3-3Describe the differences between tangible and intangible resources.
· 3-4Define capabilities and discuss their development.
· 3-5Describe four criteria used to determine if resources and capabilities are core competencies.
· 3-6Explain how firms analyze their value chain to determine where they are able to create value when using their resources, capabilities, and core competencies.
· 3-7Define outsourcing and d ...
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Figure 2.2The Five Forces of Competition Model
The five forces of competition model depicted in Figure 2.2 expands the scope of a firm’s competitive analysis. Historically, when studying the competitive environment, firms concentrated on companies with which they directly competed. However, firms must search more broadly to recognize current and potential competitors by identifying potential customers as well as the firms serving them. For example, the communications industry is now broadly defined as encompassing media companies, telecoms, entertainment companies, and companies producing devices such as smartphones. In such an environment, firms must study many other industries to identify companies with capabilities (especially technology-based capabilities) that might be the foundation for producing a good or a service that can compete against what they are producing.
When studying the industry environment, firms must also recognize that suppliers can become a firm’s competitors (by integrating forward) as can buyers (by integrating backward). For example, several firms have integrated forward in the pharmaceutical industry by acquiring distributors or wholesalers. In addition, firms choosing to enter a new market and those producing products that are adequate substitutes for existing products can become a company’s competitors.
Next, we examine the five forces the firm needs to analyze in order to understand the profitability potential within an industry (or a segment of an industry) in which it competes or may choose to compete.
The Internal Organization: Resources, Capabilities, Core Competencies, and Competitive Advantages
· Chapter Introduction
· 3-1Analyzing the Internal Organization
· 3-1aThe Context of Internal Analysis
· 3-1bCreating Value
· 3-1cThe Challenge of Analyzing the Internal Organization
· 3-2Resources, Capabilities, and Core Competencies
· 3-2aResources
· 3-2bCapabilities
· 3-2cCore Competencies
· 3-3Building Core Competencies
· 3-3aThe Four Criteria of Sustainable Competitive Advantage
· 3-3bValue Chain Analysis
· 3-4Outsourcing
· 3-5Competencies, Strengths, Weaknesses, and Strategic Decisions
· Chapter Review
· Summary
· Key Terms
· Review Questions
· Mini-Case Is Strengthening the Superdry Brand a Foundation to Strategic Success?Chapter Introduction
iStock.com/DNY59Learning Objectives
Studying this chapter should provide you with the strategic management knowledge needed to:
· 3-1Explain why firms need to study and understand their internal organization.
· 3-2Define value and discuss its importance.
· 3-3Describe the differences between tangible and intangible resources.
· 3-4Define capabilities and discuss their development.
· 3-5Describe four criteria used to determine if resources and capabilities are core competencies.
· 3-6Explain how firms analyze their value chain to determine where they are able to create value when using their resources, capabilities, and core competencies.
· 3-7Define outsourcing and d.
Healthcare Sector Analysis PowerPoint Presentation Slides
Presenting this set of slides with name - Healthcare Sector Analysis Powerpoint Presentation Slides. Keep your audience glued to their seats with professionally designed PPT slides. This deck comprises of total of sixty four slides. It has PPT templates with creative visuals and well researched content. Not just this, our PowerPoint professionals have crafted this deck with appropriate diagrams, layouts, icons, graphs, charts and more. This content ready presentation deck is fully editable. Just click the DOWNLOAD button below. Change the colour, text and font size. You can also modify the content as per your need. Get access to this well crafted complete deck presentation and leave your audience stunned.
Vivid Provider Mini Capabilities 2009
VIVID approach to supporting providers treating hard-to-reach consumers...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Due Diligence - New Strategies for Successful Licensing Acquisitions , DIA , Session Panel, June 22 2008,
Pharmaceutical Competitive Intelligence: An Essential Pill in the Pharmaceuti...
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements.
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements.
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements. Source: https://www.wns.com/perspectives/articles/articledetail/123/competitive-intelligence-an-essential-pill-in-the-pharmaceutical-kit
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements.
Pharmaceutical Contract Manufacturing
Advances and investment in digital health is growing at an incredible rate and Contract Manufacturing Organizations and Contract Development and Manufacturing Organizations are becoming an essential part of the new pharma value chain. From wearables, to apps, to digital platforms, the data and efficiencies generated by these innovations are opening up important avenues across the pharma ecosystem. As pressure on improving drug development heats up, data, digital and technological innovations are critical to delivering the desired business and patient outcomes, promoting significantly more networking and outsourcing strategies. CMOs are evolving from service providers to strategic partners. CMOs now cover the entire value chain of pharma production, including specialized services such as R&D.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today! Learn more here.
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Want to know more regarding this topic area? Then join us at our
IDMP Implementation - Impact on Data, Systems and Processes
24 – 25 June 2015 | Steigenberger Hotel Berlin, Germany
For more information take a look at our agenda here: http://bit.ly/IDMP_agenda
Or visit our website: http://bit.ly/IDMP_website
Mass Connect Request for Plans
Are you interested in starting a life sciences based company, either as a founder or entrepreneur? MassCONNECT can assist you in getting your ideas and technology crystallized into a business opportunity for presentation to the investment community.
More Related Content
Similar to Pharm2 market - Business Intelligence for Biotechs
PCD PHARMA FRANCHISE COMPANY - AROGYA FORMULATIONS PVT LTD..pptx
Arogya Formulations is a leading PCD Pharma Franchise Company that specializes in offering a wide range of high-quality pharmaceutical products. With a commitment to health and wellness, the company provides excellent opportunities for individuals and businesses to join their PCD (Propaganda Cum Distribution) Pharma franchise network. Arogya Formulations focuses on delivering innovative and affordable healthcare solutions, ensuring the availability of top-notch pharmaceutical products across various therapeutic segments. The company's dedication to quality, integrity, and customer satisfaction makes it a trusted partner for those seeking to establish a successful presence in the pharmaceutical industry through franchise opportunities.
Visit us at: https://arogyaformulations.com/pcd-pharma-franchise-company/
How is digital innovation affecting the pharmaceutical industry- Presentation
The GrowthEnabler InFocus reports uniquely address the top priorities for technology leaders and their teams; by recommending potential solutions, in the context of business growth. Each business priority is broken down to point level/function-specific solutions that are further linked to technologies with a list of vendors. Business Solutions are sourced from GrowthEnabler Pii, our intelligence gateway to over 525K high growth tech companies. This report is designed to navigate the ever-changing technology landscape, and enable more informed, and quicker, decision making.
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Figure 2.2The Five Forces of Competition Model
The five forces of competition model depicted in Figure 2.2 expands the scope of a firm’s competitive analysis. Historically, when studying the competitive environment, firms concentrated on companies with which they directly competed. However, firms must search more broadly to recognize current and potential competitors by identifying potential customers as well as the firms serving them. For example, the communications industry is now broadly defined as encompassing media companies, telecoms, entertainment companies, and companies producing devices such as smartphones. In such an environment, firms must study many other industries to identify companies with capabilities (especially technology-based capabilities) that might be the foundation for producing a good or a service that can compete against what they are producing.
When studying the industry environment, firms must also recognize that suppliers can become a firm’s competitors (by integrating forward) as can buyers (by integrating backward). For example, several firms have integrated forward in the pharmaceutical industry by acquiring distributors or wholesalers. In addition, firms choosing to enter a new market and those producing products that are adequate substitutes for existing products can become a company’s competitors.
Next, we examine the five forces the firm needs to analyze in order to understand the profitability potential within an industry (or a segment of an industry) in which it competes or may choose to compete.
The Internal Organization: Resources, Capabilities, Core Competencies, and Competitive Advantages
· Chapter Introduction
· 3-1Analyzing the Internal Organization
· 3-1aThe Context of Internal Analysis
· 3-1bCreating Value
· 3-1cThe Challenge of Analyzing the Internal Organization
· 3-2Resources, Capabilities, and Core Competencies
· 3-2aResources
· 3-2bCapabilities
· 3-2cCore Competencies
· 3-3Building Core Competencies
· 3-3aThe Four Criteria of Sustainable Competitive Advantage
· 3-3bValue Chain Analysis
· 3-4Outsourcing
· 3-5Competencies, Strengths, Weaknesses, and Strategic Decisions
· Chapter Review
· Summary
· Key Terms
· Review Questions
· Mini-Case Is Strengthening the Superdry Brand a Foundation to Strategic Success?Chapter Introduction
iStock.com/DNY59Learning Objectives
Studying this chapter should provide you with the strategic management knowledge needed to:
· 3-1Explain why firms need to study and understand their internal organization.
· 3-2Define value and discuss its importance.
· 3-3Describe the differences between tangible and intangible resources.
· 3-4Define capabilities and discuss their development.
· 3-5Describe four criteria used to determine if resources and capabilities are core competencies.
· 3-6Explain how firms analyze their value chain to determine where they are able to create value when using their resources, capabilities, and core competencies.
· 3-7Define outsourcing and d ...
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Figure 2.2The Five Forces of Competition Model
The five forces of competition model depicted in Figure 2.2 expands the scope of a firm’s competitive analysis. Historically, when studying the competitive environment, firms concentrated on companies with which they directly competed. However, firms must search more broadly to recognize current and potential competitors by identifying potential customers as well as the firms serving them. For example, the communications industry is now broadly defined as encompassing media companies, telecoms, entertainment companies, and companies producing devices such as smartphones. In such an environment, firms must study many other industries to identify companies with capabilities (especially technology-based capabilities) that might be the foundation for producing a good or a service that can compete against what they are producing.
When studying the industry environment, firms must also recognize that suppliers can become a firm’s competitors (by integrating forward) as can buyers (by integrating backward). For example, several firms have integrated forward in the pharmaceutical industry by acquiring distributors or wholesalers. In addition, firms choosing to enter a new market and those producing products that are adequate substitutes for existing products can become a company’s competitors.
Next, we examine the five forces the firm needs to analyze in order to understand the profitability potential within an industry (or a segment of an industry) in which it competes or may choose to compete.
The Internal Organization: Resources, Capabilities, Core Competencies, and Competitive Advantages
· Chapter Introduction
· 3-1Analyzing the Internal Organization
· 3-1aThe Context of Internal Analysis
· 3-1bCreating Value
· 3-1cThe Challenge of Analyzing the Internal Organization
· 3-2Resources, Capabilities, and Core Competencies
· 3-2aResources
· 3-2bCapabilities
· 3-2cCore Competencies
· 3-3Building Core Competencies
· 3-3aThe Four Criteria of Sustainable Competitive Advantage
· 3-3bValue Chain Analysis
· 3-4Outsourcing
· 3-5Competencies, Strengths, Weaknesses, and Strategic Decisions
· Chapter Review
· Summary
· Key Terms
· Review Questions
· Mini-Case Is Strengthening the Superdry Brand a Foundation to Strategic Success?Chapter Introduction
iStock.com/DNY59Learning Objectives
Studying this chapter should provide you with the strategic management knowledge needed to:
· 3-1Explain why firms need to study and understand their internal organization.
· 3-2Define value and discuss its importance.
· 3-3Describe the differences between tangible and intangible resources.
· 3-4Define capabilities and discuss their development.
· 3-5Describe four criteria used to determine if resources and capabilities are core competencies.
· 3-6Explain how firms analyze their value chain to determine where they are able to create value when using their resources, capabilities, and core competencies.
· 3-7Define outsourcing and d.
Healthcare Sector Analysis PowerPoint Presentation Slides
Presenting this set of slides with name - Healthcare Sector Analysis Powerpoint Presentation Slides. Keep your audience glued to their seats with professionally designed PPT slides. This deck comprises of total of sixty four slides. It has PPT templates with creative visuals and well researched content. Not just this, our PowerPoint professionals have crafted this deck with appropriate diagrams, layouts, icons, graphs, charts and more. This content ready presentation deck is fully editable. Just click the DOWNLOAD button below. Change the colour, text and font size. You can also modify the content as per your need. Get access to this well crafted complete deck presentation and leave your audience stunned.
Vivid Provider Mini Capabilities 2009
VIVID approach to supporting providers treating hard-to-reach consumers...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Due Diligence - New Strategies for Successful Licensing Acquisitions , DIA , Session Panel, June 22 2008,
Pharmaceutical Competitive Intelligence: An Essential Pill in the Pharmaceuti...
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements.
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements.
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements. Source: https://www.wns.com/perspectives/articles/articledetail/123/competitive-intelligence-an-essential-pill-in-the-pharmaceutical-kit
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Discover how competitive intelligence in pharma generates insightful data highlighting the capabilities of pharma businesses to meet patient requirements.
Pharmaceutical Contract Manufacturing
Advances and investment in digital health is growing at an incredible rate and Contract Manufacturing Organizations and Contract Development and Manufacturing Organizations are becoming an essential part of the new pharma value chain. From wearables, to apps, to digital platforms, the data and efficiencies generated by these innovations are opening up important avenues across the pharma ecosystem. As pressure on improving drug development heats up, data, digital and technological innovations are critical to delivering the desired business and patient outcomes, promoting significantly more networking and outsourcing strategies. CMOs are evolving from service providers to strategic partners. CMOs now cover the entire value chain of pharma production, including specialized services such as R&D.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today! Learn more here.
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Want to know more regarding this topic area? Then join us at our
IDMP Implementation - Impact on Data, Systems and Processes
24 – 25 June 2015 | Steigenberger Hotel Berlin, Germany
For more information take a look at our agenda here: http://bit.ly/IDMP_agenda
Or visit our website: http://bit.ly/IDMP_website
Mass Connect Request for Plans
Are you interested in starting a life sciences based company, either as a founder or entrepreneur? MassCONNECT can assist you in getting your ideas and technology crystallized into a business opportunity for presentation to the investment community.
Similar to Pharm2 market - Business Intelligence for Biotechs (20)
PCD PHARMA FRANCHISE COMPANY - AROGYA FORMULATIONS PVT LTD..pptx
PCD PHARMA FRANCHISE COMPANY - AROGYA FORMULATIONS PVT LTD..pptx
How is digital innovation affecting the pharmaceutical industry- Presentation
How is digital innovation affecting the pharmaceutical industry- Presentation
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Figure 2.2The Five Forces of Competition ModelThe five forces .docx
Healthcare Sector Analysis PowerPoint Presentation Slides
Healthcare Sector Analysis PowerPoint Presentation Slides
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Pharmaceutical Competitive Intelligence: An Essential Pill in the Pharmaceuti...
Pharmaceutical Competitive Intelligence: An Essential Pill in the Pharmaceuti...
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Competitive Intelligence: An Essential Pill in the Pharmaceutical Kit
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Drug and Device Combinations- The Leadership Challenge
Drug and Device Combinations- The Leadership Challenge
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptx
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptx
Pharm2 market - Business Intelligence for Biotechs
- 1. Pharm2Market Business Intelligence for Biotechs
- 2. Challenges Drug discovery communities are complex, multi-layered, and multi-player. Commercial databases that attempt to cover this space are often: ● Out-of-date ● Built for the wrong audience (fin-tech vs biotech BD) ● Don’t include the scientific and business knowledge required by business development professionals in this space
- 3. Pharm2Market Covers The Community Pipeline Targets Drugs Clinical Trials Networking Events Investors News Real Estate Lab Equipment & Supplies Resources Recruiting Consulting, CROs, CMOs Legal Advice Twitter LinkedIn Indeed Companies
- 4. Portfolio Management Add companies to your portfolio to track companies of specific interest Tag companies for follow-up and deal-flow management Add notes Leverage LinkedIn for contact management
- 5. Pipelines, Targets, Drugs, Clinical Trials Pharm2Market tracks the pipelines of drug discovery companies in your community. Including the therapeutic areas, therapeutic classes, indications, targets, drugs and clinical trials. Find new opportunities by comparing your current customers against similar companies
- 6. News The pharmaceutical industry is extremely dynamic. The News page consolidates all of the news relevant to your business. Track news at the community and industry level. Track news from companies in your portfolio.
- 7. Networking Find the latest networking opportunities in your communities and connect with the people who can change your business. Pharm2Market tracks local professional societies and their events and makes it easy to signup.
- 8. Activity Feed Company information is constantly being updated, the activity feed helps you keep on top of it all: ● Company Updates ● Investor Updates ● Event Updates
- 9. Pharm2Market Growing Pharm2Market is currently launching in the San Diego market with over 240 companies in our database and more being added daily. Launches for San Francisco, and Boston planned for Q1-19.
- 10. Concierge Service Tell us what you’re looking for, and leave the detective work to us.